$11.38
0.010.09%
At Close: -
$11.38
00.00%
After Hours: 1:01 PM EDT
15 minutes delayed
Y-mAbs Therapeutics
YMABNASDAQ
Y-mAbs Therapeutics (YMAB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestY-mAbs Therapeutics (NASDAQ:YMAB) Stock Quotes, Forecast and News Summary
Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
| Open | $11.43 |
| Close | $11.38 |
| Volume / Avg. | 123.97K / 364.41K |
| Day Range | 11.24 - 11.59 |
| 52 Wk Range | 4.60 - 20.90 |
| Market Cap | $499.38M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 10.03% |
| Days to Cover | 13.24 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Y-Mabs Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Y-mAbs Therapeutics (YMAB) stock?
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Who are Y-mAbs Therapeutics (YMAB) competitors?
Other companies in Y-mAbs Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
What is the target price for Y-mAbs Therapeutics (YMAB) stock?
There is no analysis for Y-mAbs Therapeutics.
What is the forecast for Y-mAbs Therapeutics (YMAB) stock?
Y-mAbs Therapeutics has a consensus price target of $14.33.
Current stock price for Y-mAbs Therapeutics (YMAB)?
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $11.38 last updated July 3, 2024 at 1:01 PM EDT.
Does Y-mAbs Therapeutics (YMAB) pay a dividend?
There are no upcoming dividends for Y-mAbs Therapeutics.
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Y-mAbs Therapeutics (YMAB) going to split?
There is no upcoming split for Y-mAbs Therapeutics.
What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.